IO Biotech Inc (IOBT)

Currency in USD
0.641
+0.009(+1.42%)
Closed·
0.649+0.008(+1.25%)
·
IOBT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.6000.656
52 wk Range
0.3232.790
Key Statistics
Prev. Close
0.641
Open
0.643
Day's Range
0.6-0.656
52 wk Range
0.323-2.79
Volume
1.09M
Average Volume (3m)
3.7M
1-Year Change
-25.48%
Book Value / Share
0.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IOBT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.463
Upside
+284.29%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

IO Biotech Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

IO Biotech Inc Company Profile

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company’s lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGFß1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.

Compare IOBT to Peers and Sector

Metrics to compare
IOBT
Peers
Sector
Relationship
P/E Ratio
−0.5x−3.0x−0.6x
PEG Ratio
−0.20−0.090.00
Price/Book
50.6x3.4x2.6x
Price / LTM Sales
-20.6x3.3x
Upside (Analyst Target)
383.1%142.1%41.4%
Fair Value Upside
Unlock6.8%6.0%Unlock

Analyst Ratings

2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.463
(+284.29% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Buy3.00+368.02%-MaintainNov 19, 2025
Piper Sandler
Buy3.00+368.02%10.00MaintainOct 22, 2025
TD Cowen
Hold---DowngradeSep 30, 2025
Morgan Stanley
Hold0.39-39.16%40.00DowngradeSep 30, 2025
H.C. Wainwright
Hold---DowngradeSep 29, 2025

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
-0.13 / -0.35
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

IOBT Income Statement

People Also Watch

0.410
INTS
+15.16%
0.608
SCNX
+9.94%
1.680
CMBM
+5.66%
0.729
BKYI
+3.40%

FAQ

What Is the IO Biotech (IOBT) Premarket Price Today?

The IO Biotech (IOBT) premarket price is 0.649. Premarket price change units: 0.008. Premarket percentage change: 1.250%. Premarket volume: 860.000. Current date: 04 Dec 2025. Previous close: 0.641

What Stock Exchange Does IO Biotech Trade On?

IO Biotech is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for IO Biotech?

The stock symbol for IO Biotech is "IOBT."

What Is the IO Biotech (IOBT) Afterhours Price Today? (Afterhours variable test: 0.669) Current Date: 04 Dec 2025

After hours price: 0.669. After hours price change (units): 0.028. Price change percentage: 4.370%

What Is the IO Biotech Market Cap?

As of today, IO Biotech market cap is 46.13M.

What Is IO Biotech's Earnings Per Share (TTM)?

The IO Biotech EPS (TTM) is -1.34.

When Is the Next IO Biotech Earnings Date?

IO Biotech will release its next earnings report on 03 Mar 2026.

From a Technical Analysis Perspective, Is IOBT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has IO Biotech Stock Split?

IO Biotech has split 0 times.

How Many Employees Does IO Biotech Have?

IO Biotech has 80 employees.

What is the current trading status of IO Biotech (IOBT)?

As of 04 Dec 2025, IO Biotech (IOBT) is trading at a price of 0.641, with a previous close of 0.641. The stock has fluctuated within a day range of 0.600 to 0.656, while its 52-week range spans from 0.323 to 2.790.

What Is IO Biotech (IOBT) Price Target According to Analysts?

The average 12-month price target for IO Biotech is USD2.46333, with a high estimate of USD4 and a low estimate of USD0.39. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +284.29% Upside potential.

What Is the IOBT Premarket Price?

IOBT's last pre-market stock price is 0.649. The pre-market share volume is 860.000, and the stock has decreased by 0.008, or 1.250%.

What Is the IOBT After Hours Price?

IOBT's last after hours stock price is 0.669, the stock has decreased by 0.028, or 4.370%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.